While Fosamax was initially hailed as a breakthrough treatment, reports began to emerge soon after its approval linking long-term use of the drug to “atypical femoral fractures”—unusual but ...

Bisphosphonates are the mainstay of osteoporosis therapy. Extensive clinical evaluation supports their utility in stemming progression of the disease and in reducing fracture risk. In the course ...